|
Liothyronine SodiumDrug - Liothyronine Sodium The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Liothyronine Sodium
Strength -
EQ 0.025MG BASE
Applicant -
WATSON LABS
New Drug Application (NDA) Number -
085755
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Jan 25, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Watson Laboratories Inc
Liothyronine Sodium
Zyvox 600mg Tablet; Oral
Liothyronine Sodium Eq 0.01mg Base/ml Injectable; Injection Triostat Eq 0.01mg Base/ml Injectable; Injection Cytomel Eq 0.005mg Base Tablet; Oral Cytomel Eq 0.025mg Base Tablet; Oral Cytomel Eq 0.05mg Base Tablet; Oral Liothyronine Sodium Eq 0.025mg Base Tablet; Oral Zyvox 100mg/5ml For Suspension; Oral Zyvox 200mg/100ml Injectable; Injection Zyvox 400mg **federal Register Determination That Product Was Not Discontinued Or Withdrawn For Safety Or Efficacy Reasons** Tablet; Oral NewDrugInformation |